YCK Diabetes Assessment Centre, Prince of Wales Hospital
Welcome,         Profile    Billing    Logout  
 4 Trials 
4 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Chan, Juliana CN
NCT05268237: Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus

Recruiting
1/2
15
RoW
Liraglutide, Placebo
Biolingus, Chinese University of Hong Kong
Diabete Type 2
05/24
07/24
NCT04441216: Effects of TCM on Beta-cell Function and Insulin Resistance in High Risk Chinese Individuals for T2D (TCM_PDiab_P01)

Recruiting
N/A
40
RoW
Rhizoma Coptidis, Radix Astragali and Flos Lonicerae, Rhizoma Coptidis, Radix Astragali and Flos Lonicerae, Ophiopogonis Radix
Chinese University of Hong Kong
Prediabetic State
06/23
06/23
CRE-2024.243, NCT06693934: Jockey Club Precision Prevention Programme on Young Onset Diabetes

Not yet recruiting
N/A
9000
RoW
Risk assessment with biogenetic and clinical test to predict diabetes risk, Oral glucose tolerance test (OGTT) and cardiovascular-kidney-metabolic (CKM) risk factors, Medication, Continuous glucose monitoring (CGM) devices and/or weighing scale, Visit to family doctor with nurse education, Joint Asia Diabetes Evaluation (JADE) assessment, Education webinars, workshops and health messages
Juliana CN Chan, Chinese University of Hong Kong, St James' Settlement, Asia Diabetes Foundation
Diabetes, Pre Diabetes, Hypertension, Dyslipidemia, Obesity
10/27
05/28
NCT04049149: Precision Medicine in Chinese Patients With Young Onset Diabetes

Active, not recruiting
N/A
884
RoW
Biogenetic explanation and endocrinologist intensive managment, Usual care management
Chinese University of Hong Kong
Type 2 Diabetes
12/24
12/24

Download Options